Although the exact mechanism(s) of action of UCP2 have yet to be fully defined, the manipulation of the expression or activity of UCP2 leads to such strong effects on neurodegenerative disease that this protein is clearly a high priority as a drug target. This evidence concerns the gene UCP2 and neurodegenerative disease.